Fidelity Select Portfolios - Medical Technology and Devices Portfolio Profit Margin

As of the most recent data (September 2023), FSMEX shows a profit margin of -13.9%. That compares with -242.31% in the prior-year period — up 94.3% year over year. That is below the sector sector average of 19.74%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FSMEX's profit margin is now -13.9% (was -242.31%) — a 94.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fidelity Select Portfolios - Medical Technology and Devices Portfolio is outperforming or lagging.

The its sector sector average profit margin is about 19.74%. Fidelity Select Portfolios - Medical Technology and Devices Portfolio is at -13.9%, which is lower that average. That is roughly 170.4% below the sector mean. Use the comparison chart on this page to see how FSMEX stacks up against individual peers as well.

That compares with -242.31% in the prior-year period — up 94.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Fidelity Select Portfolios - Medical Technology and Devices Portfolio with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Fidelity Select Portfolios - Medical Technology and Devices Portfolio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -13.9%) with ownership activity and broader fundamentals.